BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12518892)

  • 21. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo.
    O'Sullivan DB; Harrison PT; Sullivan AM
    J Neural Transm (Vienna); 2010 May; 117(5):559-72. PubMed ID: 20349094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of antioxidant-enriched diet for tyrosine hydroxylase-positive neurons in ventral mesencephalic tissue in oculo grafts.
    Berglöf E; Small BJ; Bickford PC; Strömberg I
    J Comp Neurol; 2009 Jul; 515(1):72-82. PubMed ID: 19399894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones.
    Karlsson J; Love RM; Clarke DJ; Brundin P
    Brain Res; 1999 Mar; 821(2):546-50. PubMed ID: 10064845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
    J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
    Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
    Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
    Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats.
    Klein A; Wessolleck J; Papazoglou A; Metz GA; Nikkhah G
    Behav Brain Res; 2009 May; 199(2):317-25. PubMed ID: 19124044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
    Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
    Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
    J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
    Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
    Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
    Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
    Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.
    Ratzka A; Kalve I; Özer M; Nobre A; Wesemann M; Jungnickel J; Köster-Patzlaff C; Baron O; Grothe C
    Cell Transplant; 2012; 21(4):749-62. PubMed ID: 21929871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.